Ecuador Grants First Compulsory Licence, For HIV/AIDS Drug 22/04/2010 by Catherine Saez, Intellectual Property Watch 7 Comments Ecuador this month granted its first compulsory licence for a patented pharmaceutical since declaring last year that it would utilise international rules allowing it to do so. The move has already brought the country substantial savings due to new competition, according to the Ecuadorean intellectual property office. Other Latin American countries might be drawn to the prospect of reduced drug prices, according to advocates. The rights owner said it is disappointed with the decision.
Geneva Health Forum Addresses Biotech, Trade, Pandemic Flu 21/04/2010 by Catherine Saez and William New, Intellectual Property Watch Leave a Comment Biotechnology, international trade, and pandemic influenza were among the topics discussed at the outset of this year’s Geneva Health Forum.
WIPO, WTO Requested To Advise On Anti-Counterfeiting Treaty 15/04/2010 by Kaitlin Mara for Intellectual Property Watch 3 Comments Several members of the European Parliament today sent letters to the directors general of the World Intellectual Property Organization and the World Trade Organization requesting technical assistance in the negotiation of an agreement that some are calling an attempt to circumvent global norms on intellectual property enforcement and related public interest flexibility.
Risk Of Wrongful Medicines Seizures Seen In EU-Central America Trade Deal 06/04/2010 by David Cronin for Intellectual Property Watch 1 Comment A new accord designed to bolster political and economic ties between the European Union and Central America could result in greater seizures of medicines whenever pharmaceutical companies allege that their patents have been infringed, public health advocates have warned.
在WHO就假冒伪劣药品问题吹风会上观点激烈交锋 03/04/2010 by Kaitlin Mara for Intellectual Property Watch Leave a Comment 世界卫生组织就处理假冒伪劣（conterfeit）药品问题继续开展工作，但是上周晚些时候召开的一个会议暴露出一些方面对该组织的工作方式表示担心。
Débat houleux lors d’une réunion d’information organisée par l’OMS sur les médicaments contrefaits 01/04/2010 by Kaitlin Mara for Intellectual Property Watch 2 Comments Alors que l’Organisation mondiale de la Santé (OMS) continue de travailler sur la question des médicaments contrefaits, une réunion organisée en fin de semaine dernière a révélé des inquiétudes quant à la manière dont ce travail est mené.
Mordaz intercambio de puntos de vista en la reunión informativa de la OMS sobre medicamentos falsificados 01/04/2010 by Kaitlin Mara for Intellectual Property Watch Leave a Comment La Organización Mundial de la Salud (OMS) continúa trabajando en el tema de los medicamentos falsificados, pero la semana pasada una reunión reveló preocupaciones progresivas sobre la forma de conducir la labor.
Pointed Exchange Of Views At WHO Briefing On Counterfeit Drugs 31/03/2010 by Kaitlin Mara for Intellectual Property Watch 1 Comment Work to address counterfeit medicines continues at the World Health Organization, but a meeting late last week revealed ongoing concerns about the way it is being conducted.
Proponents Seek To Develop Policy Potential Of US Geographical Indications 31/03/2010 by Catherine Saez, Intellectual Property Watch Leave a Comment Advocates of stronger protection of geographical indications are working to develop greater awareness in Geneva policy circles, trying to win over countries reluctant to adopt a specific GI protection system.
China Tells WTO: Obligations Fulfilled On IP Dispute Case 22/03/2010 by Kaitlin Mara for Intellectual Property Watch 1 Comment China on Friday briefed the World Trade Organization on improvements in its intellectual property rights enforcement needed to bring it into compliance with a dispute settlement decision made last year.